Skip to content
Screener

Pulse Biosciences, Inc. PLSE Q4 2025 Annual earnings

Reported February 19, 2026 · After market close

Revenue$264.0KBeat by $114.0K
EPS-$0.26Beat by $0.01
Revenue estimate$150.0K
EPS estimate-$0.27

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$620.0K
EPS estimate-$0.35

Financials

Q4 2025

Income statement

See full
Revenue$264.0K—
Gross profit-—
Operating income-$18.3M+9.9%
Net income-$17.4M+10.1%

Balance sheet

See full
Cash & equivalents$80.7M-31.6%
Total debt$7.5M-15.4%
Total equity$80.7M-29.8%
Total assets$94.5M-28.6%

Cash flow

See full
Operating cash flow-$14.8M-61.4%
CapEx$105.0K+98.1%
Free cash flow-$14.9M-61.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$930.45M-13.1%
Enterprise value$857.24M-10.9%
P/S2,658.4×—

Profitability

See full
Gross margin-55.1%—
Operating margin-21,982.6%—
Net margin-20,794.6%—
FCF margin-15,553.4%—

Returns & leverage

See full
Return on equity-74.4%+8.8pp
Debt / equity0.1×0.0×
Current ratio10.5×-1.4×

FAQ

When did Pulse Biosciences, Inc. report Q4 2025 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q4 2025 earnings on February 19, 2026 after market close.
What were Pulse Biosciences, Inc.'s Q4 2025 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of $264.0K and eps of $-0.26 for Q4 2025.
Did Pulse Biosciences, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $150.0K by $114.0K. EPS beat the consensus estimate of $-0.27 by $0.01.
How did Pulse Biosciences, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 84.1% from $1.7M a year earlier and eps declined 52.9% from $-0.17.
Where can I find Pulse Biosciences, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-26-004726) and the 10-K periodic report (0001437749-26-004724) directly on SEC EDGAR. The filing index links above go to sec.gov.